arrow
返回
D

David Elder

GlaxoSmithKline

28H指数
122论文数
3.1K被引数
收录论文 29
发表时间
Direct air capture of CO2via cyclic viologen electrocatalysis
err2024-01-01
err0
PREAI
errLiu, Shijie; Zhang, Jinqiang; Li, Feng; Edwards, Jonathan P.; Xiao, Yurou Celine; Kim, Dongha; Papangelakis, Panagiotis; Kim, Jiheon; Elder, David; De Luna, Phil; Fan, Mengyang; Lee, Geonhui; Miao, Rui Kai; Ghosh, Tanushree; Yan, Yu; Chen, Yuanjun; Zhao, Yong; Guo, Zunmin; Tian, Cong; Li, Peihao; Xu, Yi; Sargent, Edward H.; Sinton, David
err分享
err收藏
Tolerability of risk: A commentary on the nitrosamine contamination issue
err2021-06-01
err25
errOAAI
errElder, David P.; Johnson, George E.; Snodin, David J.
err分享
err收藏
New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities
err2019-10-04
err17
errOAAI
errBurns, Michael J.; Ott, Martin A.; Teasdale, Andrew; Stafford, Susanne A.; Antonucci, Vincent; Baumann, Jens-Christoph; Brown, Roland; Covey-Crump, Elizabeth M.; Elder, David; Elliott, Eric; Fennell, Jared W.; Gallou, Fabrice; Ide, Nathan D.; Itoh, Tetsuji; Jordine, Guido; Kallemeyn, Jeffrey M.; Lauwers, Dirk; Looker, Adam R.; Lovelle, Lucie E.; Molzahn, Robert; Schils, Didier; Oestrich, Rolf Schulte; Sluggett, Gregory W.; Stevenson, Neil; Talavera, Pere; Urquhart, Michael W.; Varie, David L.; Welch, Dennie S.
err分享
err收藏
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and Commercialization
err2018-01-01
err70
errOAAI
errGrady, Haiyan; Elder, David; Webster, Gregory K.; Mao, Yun; Lin, Yiqing; Flanagan, Talia; Mann, James; Blanchard, Andy; Cohen, Michael J.; Lin, Judy; Kesisoglou, Filippos; Hermans, Andre; Abend, Andreas; Zhang, Limin; Curran, David
err分享
err收藏
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies
err2017-11-01
err24
PREAI
errBarber, Chris; Antonucci, Vincent; Baumann, Jens-Christoph; Brown, Roland; Covey-Crump, Elizabeth; Elder, David; Elliott, Eric; Fennell, Jared W.; Gallou, Fabrice; Ide, Nathan D.; Jordine, Guido; Kallemeyn, Jeffrey M.; Lauwers, Dirk; Looker, Adam R.; Lovelle, Lucie E.; McLaughlin, Mark; Molzahn, Robert; Ott, Martin; Schils, Didier; Oestrich, Rolf Schulte; Stevenson, Neil; Talavera, Pere; Teasdale, Andrew; Urquhart, Michael W.; Varie, David L.; Welch, Dennie
err分享
err收藏
Antibiotic Resistance: The Need For a Global Strategy
err2016-08-01
err26
PREAI
errElder, David P.; Kuentz, Martin; Holm, Rene
err分享
err收藏
err分享
err收藏
Meeting commentary-Parkinson's disease: From patient to product
err2015-10-01
err2
errOAAI
errWahlich, John; Elder, David; Liu, Fang; Hughes, Carmel; Orlu-Gul, Mine
err分享
err收藏
Do Carboxylic/Sulfonic Acid Halides Really Present a Mutagenic and Carcinogenic Risk as Impurities in Final Drug Products?
err2015-07-15
err30
PREAI
errAmberg, Alexander; Harvey, James S.; Czich, Andreas; Spirkl, Hans-Peter; Robinson, Sharon; White, Angela; Elder, David P.
err分享
err收藏
Mutagenic Impurities: Precompetitive/Competitive Collaborative and Data Sharing Initiatives
err2015-06-17
err20
PREAI
errElder, David P.; White, Angela; Harvey, James; Teasdale, Andrew; Williams, Richard; Covey-Crump, Elizabeth
err分享
err收藏
Strategies To Address Mutagenic Impurities Derived from Degradation in Drug Substances and Drug Products
err2015-06-10
err25
PREAI
errKleinman, Mark H.; Elder, David; Teasdale, Andrew; Mowery, Mark D.; McKeown, Alan P.; Baertschi, Steven W.
err分享
err收藏